Clinical Trial Update: ToFAcitinib in Early Active Axial SpondyloarThritis: [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating tofacitinib for axial spondyloarthritis is currently recruiting at Charité University in Berlin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Axial Spondyloarthritis | Phase 4 | Status: RECRUITING